Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: A 6 year single institutional experience

Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia), Cinzia Iotti(Azienda Sanitaria Unità Locale di Reggio Emilia), Anna Pisanello, M. Galeandro, E. Cagni(Ospedale Santa Maria), A. Botti(Azienda Sanitaria Unità Locale di Reggio Emilia), Mauro Iori(Azienda Sanitaria Unità Locale di Reggio Emilia), A. Podgornii, Nunziata D’Abbiero
Clinical Neurology and Neurosurgery
February 26, 2013
10.1016/j.clineuro.2013.02.001
Cited by 19

Related Papers

Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
|Lung Cancer|2009|277
Stereotactic body radiation therapy for lung metastases
|Lung Cancer|2011|146
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
|European Urology|2021|110
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations
|Radiation Oncology|2012|109
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO
|Neuro-Oncology|2021|91